Tenaya Therapeutics (TNYA) Return on Capital Employed (2021 - 2026)
Tenaya Therapeutics (TNYA) recorded quarterly Return on Capital Employed of 69.12% in Q1 2026, up 18.15% quarter-over-quarter from 84.45% in Q4 2025, and up 2403.0% on a YoY basis from 2.76% in Q1 2025.
Tenaya Therapeutics (TNYA) Return on Capital Employed (2021 - 2026) Analysis & Trends
Tenaya Therapeutics' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 69.12% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 2403.0% year-over-year to 69.12%; the TTM figure through Mar 2026 stood at 69.12% (up 2403.0% YoY), while the FY2025 annual figure was 79.1%, up 1061.0% from the prior year.
- Return on Capital Employed was 69.12% for Q1 2026 at Tenaya Therapeutics, up from 84.45% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 32.59% in Q1 2022 to a low of 101.45% in Q4 2024.
- Historically, Return on Capital Employed has averaged 72.73% across 5 years, with a median of 80.69% in 2024.
- The sharpest annual moves came in 2022 and 2026: Return on Capital Employed plunged 3083 bps in 2022, then soared 2403 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 55.01% in 2022, then sank by 50 bps to 82.4% in 2023, then fell by 23 bps to 101.45% in 2024, then increased by 17 bps to 84.45% in 2025, then grew by 18 bps to 69.12% in 2026.
- The last three Return on Capital Employed figures came in at 69.12% (Q1 2026), 84.45% (Q4 2025), and 96.86% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Tenaya Therapeutics | 158.32 Mn | 158.32 Mn | - | -69.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.12% |
| Dec 31, 2025 | -84.45% |
| Sep 30, 2025 | -96.86% |
| Jun 30, 2025 | -85.54% |
| Mar 31, 2025 | -93.15% |
| Dec 31, 2024 | -101.45% |
| Sep 30, 2024 | -90.45% |
| Jun 30, 2024 | -80.69% |
| Mar 31, 2024 | -82.77% |
| Dec 31, 2023 | -82.40% |
| Sep 30, 2023 | -71.55% |
| Jun 30, 2023 | -63.49% |
| Mar 31, 2023 | -52.79% |
| Dec 31, 2022 | -55.01% |
| Sep 30, 2022 | -52.48% |
| Jun 30, 2022 | -41.70% |
| Mar 31, 2022 | -32.59% |
| Dec 31, 2021 | -24.17% |
| Sep 30, 2021 | -24.70% |